ARTICLE | Clinical News
Epuris regulatory update
December 3, 2012 8:00 AM UTC
Cipher said Health Canada approved an NDS for Epuris Cip-isotretinoin to treat severe, recalcitrant, nodular acne in patients >=12 years. The company said it plans to launch the product in Canada in 2...